Eloctate 3000 Unit (Antihemophilic Factor (Recombinant Bdd), Fc Fusion Protein KIT) 3000 UNIT

ELOCTATE 3000 Unit is a recombinant antihemophilic factor used for hemophilia B treatment. This intravenous kit helps manage bleeding episodes and prevent complications.

Strength

3000 UNIT

Pack Size

3ML

Manufacturer / TM Owner

SANOFI-AVENTIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ELOCTATE 3000 Unit is primarily used for the treatment and prevention of bleeding episodes in patients with hemophilia B, a genetic disorder that affects blood clotting. This medication is designed to replace the missing clotting factor IX, which is essential for proper blood coagulation. It is often used in situations where bleeding control is critical, such as during surgery or after an injury.

Side Effects

Common effects of ELOCTATE 3000 Unit may include localized reactions at the injection site, such as redness, swelling, or discomfort. Some users may also experience mild flu-like symptoms, including headache or fatigue. These effects are generally temporary and should subside as the body adjusts to the medication.

Precautions & Warnings

ELOCTATE 3000 Unit should be handled with care and stored as per the manufacturer's instructions to maintain its efficacy. It is important to use this medication under the supervision of a healthcare professional, especially for intravenous administration. Always check the packaging for any visible signs of damage or contamination before use.

Avoid Interactions

ELOCTATE 3000 Unit may interact with other medications, particularly those that affect blood clotting. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also influence the effectiveness of this medication.

Frequently Asked Questions

ELOCTATE 3000 Unit is used to treat and prevent bleeding episodes in patients with hemophilia B.

ELOCTATE 3000 Unit is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include localized reactions at the injection site and mild flu-like symptoms.

ELOCTATE 3000 Unit is specifically designed for hemophilia B and should not be used for other types of hemophilia without medical advice.

ELOCTATE 3000 Unit should be stored according to the manufacturer's instructions to maintain its efficacy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.